Table of Content

1. Executive Summary


2. China IVD Market and Market Share Analysis (2014 - 2030)

2.1 China IVD Market and Forecast
2.2 China IVD Market Share and Forecast - By Segment
2.3 China IVD Market Share and Forecast - By Company


3. China IVD - Segments Wise Market and Forecast (2014 - 2030)

3.1 China Clinical Chemistry Market and Forecast
3.2 China Immunoassay Market and Forecast
3.3 China Hematology Market and Forecast
3.4 China Coagulation Market and Forecast
3.5 China Microbiology Market and Forecast
3.6 China Molecular Testing Market and Forecast
3.7 China Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
3.8 China Point of Care Testing (POCT) Market and Forecast


4. Development Environment of Chinese IVD Industry

4.1 State Healthcare Reforms
4.2 State Citizen-Benefiting Policies
4.3 Requirements of Hospital Upgrading
4.4 Healthy China 2030


5. Profile of In-vitro Diagnostic Reagents Registration Control

5.1 Classification of In-vitro Diagnostic Reagents in China

5.1.1 Class III: Highest Risk
5.1.2 Class II: Medium Risk
5.1.3 Class I: Lower Risk

5.2 Regulatory History in China IVD Market

5.3 Regulatory Status in China IVD Market

5.3.1 Blood Screening Reagents - Drug Administration
5.3.2 Varieties of Blood Screening Reagents
5.3.3 Blood Screening Reagent Test
5.3.4 Nucleic Acid Detection Kits for Blood Screening
5.3.5 Radioactive reagents - Drug Administration
5.3.6 Diagnostic Reagents - Medical Devices Management

5.4 Regulatory Trend in China IVD Market

5.4.1 Blood Screening Reagents Belonging
5.4.2 Quality Improvement
5.4.3 Pre-Evaluation of Registration Standards


6. Registration for In Vitro Diagnostic Reagents in China

6.1 Registration and Filing
6.2 Filing Obligation for Clinical Trials
6.3 Clinical Trial Institutions
6.4 Elimination of IVD Loophole for Research
6.5 Change of Manufacturing Address
6.6 Change of Main Supplier of An Antigen or Antibody
6.7 China In Vitro Diagnostics Registration Update

6.7.1 IVD Product Registration in China
6.7.2 China IVD Type Testing Process
6.7.3 Clinical Trials for IVD Products in China


7. Reimbursement of IVD Products in China


8. China IVD Market - Key Players Sales Analysis (2015 - 2030)

8.1 Roche Diagnostics

8.1.1 Company Overview
8.1.2 Roche Diagnostics - China IVD Sales and Forecast
8.1.3 Recent Developments

8.2 Abbott Laboratories

8.2.1 Company Overview
8.2.2 Abbott Laboratories - China IVD Sales and Forecast
8.2.3 Recent Developments

8.3 Sysmex Corporation

8.3.1 Company Overview
8.3.2 Sysmex Corporation - China IVD Sales and Forecast
8.3.3 Recent Developments

8.4 Mindray Medical International Limited

8.4.1 Company Overview
8.4.2 Mindray Medical International Limited - China IVD Sales and Forecast
8.4.3 Recent Developments

8.5 Shanghai Kehua Bio-Engineering Co. Ltd.

8.5.1 Business Overview
8.5.2 Shanghai Kehua Bio-Engineering Co. Ltd. - China IVD Sales & Forecast
8.5.3 Recent Developments

8.6 bioM?rieux S.A.

8.6.1 Business Overview
8.6.2 bioM?rieux SA - China IVD Sales & Forecast
8.6.3 Recent Developments

8.7 Bio-Rad Laboratories, Inc.

8.7.1 Company Overview
8.7.2 Bio-Rad Laboratories, Inc. - China IVD Sales & Forecast
8.7.3 Recent Developments

8.8 Danaher Corporation

8.8.1 Company Overview
8.8.2 Danaher Corporation - China IVD Sales & Forecast
8.8.3 Recent Developments

8.9 Thermo Fisher Scientific Inc.

8.9.1 Company Overview
8.9.2 Thermo Fisher Scientific Inc. - China IVD Sales & Forecast
8.9.3 Recent Developments

8.10 Snibe Diagnostic

8.10.1 Company Overview
8.10.2 Snibe Diagnostic - Global IVD Sales
8.10.3 Recent Developments

8.11 Dirui Medical

8.11.1 Company Overview
8.11.2 Dirui Medical - Global Sales

8.12 Autobio Diagnostics

8.12.1 Company Overview
8.12.2 Autobio Diagnostics - Global Sales
8.12.3 Recent Developments

8.13 YHLO Biotech

8.13.1 Company Overview
8.13.2 YHLO Biotech – Global Sales
8.13.3 Recent Developments

8.14 Beijing Strong Biotechnologies, Inc.

8.14.1 Company Overview
8.14.2 Beijing Strong Biotechnologies, Inc. - China IVD Sales
8.14.3 Recent Developments

8.15 Others - China IVD Sales and Forecast


9. Profiles of Select Clinical Labs and Diagnostic Services Companies

9.1 Dian Diagnostics Group Co. Ltd. (Formerly Zhejiang Di’an Diagnostics Technology Co., Ltd.)

9.1.1 Company Overview
9.1.2 Products and Services Offered by Di’an

9.2 ADICON Clinical Laboratories

9.2.1 Company Overview
9.2.2 Products and Services Offered by ADICON
9.3 Guangzhou KingMed Diagnostics Center Co. Ltd.
9.3.1 Company Overview
9.3.2 Products and Services Offered by KingMed

9.4 Kindstar Global

9.4.1 Company Overview
9.4.2 Products and Services Offered by Kindstar

9.5 BGI Group

9.5.1 Company Overview

9.6 OriGene Technologies

9.6.1 Company Overview
9.6.2 Products and Services Offered by OriGene


10. In-Vitro Diagnostics (IVD) Market - Major Deals


11. In-Vitro Diagnostics (IVD) Market - Recent Developments


12. China In–Vitro Diagnostics – Market Dynamics

12.1 China IVD Market - Driving Factors
12.2 China IVD Market - Challenges



List of Figures

List of Figures:

Figure 2-1: China - IVD Market (Million US$), 2014 - 2023
Figure 2-2: China - Forecast for IVD Market (Million US$), 2024 - 2030

Figure 3-1: China - Clinical Chemistry Market (Million US$), 2014 - 2023
Figure 3-2: China - Forecast for Clinical Chemistry Market (Million US$), 2024 - 2030
Figure 3-3: China - Immunoassay Market (Million US$), 2014 - 2023
Figure 3-4: China - Forecast for Immunoassay Market (Million US$), 2024 - 2030
Figure 3-5: China - Hematology Market (Million US$), 2014 - 2023
Figure 3-6: China - Forecast for Hematology Market (Million US$), 2024 - 2030
Figure 3-7: China - Coagulation Market (Million US$), 2014 - 2023
Figure 3-8: China - Forecast for Coagulation Market (Million US$), 2024 - 2030
Figure 3-9: China - Microbiology Market (Million US$), 2014 - 2023
Figure 3-10: China - Forecast for Microbiology Market (Million US$), 2024 - 2030
Figure 3-11: China - Molecular Testing Market (Million US$), 2014 - 2023
Figure 3-12: China - Forecast for Molecular Testing Market (Million US$), 2024 - 2030
Figure 3-13: China - SMBG Market (Million US$), 2014 - 2023
Figure 3-14: China - Forecast for SMBG Market (Million US$), 2024 - 2030
Figure 3-15: China - POCT Market (Million US$), 2014 - 2023
Figure 3-16: China - Forecast for POCT Market (Million US$), 2024 - 2030

Figure 8-1: Roche Diagnostics - China IVD Revenue (Million US$), 2015 - 2023
Figure 8-2: Roche Diagnostics - Forecast for China IVD Revenue (Million US$), 2024 - 2030
Figure 8-3: Abbott Laboratories - China IVD Revenue (Million US$), 2015 - 2023
Figure 8-4: Abbott Laboratories - Forecast for China IVD Revenue (Million US$), 2024 - 2030
Figure 8-5: Sysmex Corporation - China IVD Revenue (Million US$), 2015 - 2023
Figure 8-6: Sysmex Corporation - Forecast for China IVD Revenue (Million US$), 2024 - 2030
Figure 8-7: Mindray Medical - China IVD Revenue (Million US$), 2015 - 2023
Figure 8-8: Mindray Medical - Forecast for China IVD Revenue (Million US$), 2024 - 2030
Figure 8-9: Shanghai Kehua - China IVD Revenue (Million US$), 2015 - 2023
Figure 8-10: Shanghai Kehua - Forecast for China IVD Revenue (Million US$), 2024 - 2030
Figure 8-11: bioM?rieux SA - China IVD Revenue (Million US$), 2015 - 2023
Figure 8-12: bioM?rieux SA - Forecast for China IVD Revenue (Million US$), 2024 - 2030
Figure 8-13: Bio-Rad Laboratories, Inc. - China IVD Revenue (Million US$), 2015 - 2023
Figure 8-14: Bio-Rad Laboratories, Inc. - Forecast for China IVD Revenue (Million US$), 2024 - 2030
Figure 8-15: Danaher Corporation - China IVD Revenue (Million US$), 2015 - 2023
Figure 8-16: Danaher Corporation - Forecast for China IVD Revenue (Million US$), 2024 - 2030
Figure 8-17: Thermo Fisher Scientific Inc. - China IVD Revenue (Million US$), 2015 - 2023
Figure 8-18: Thermo Fisher Scientific Inc. - Forecast for China IVD Revenue (Million US$), 2024 - 2030
Figure 8-19: Snibe Diagnostic - Global IVD Revenue (Million US$), 2018 – 2023e
Figure 8-20: Dirui Medical - Global Revenue (Million US$), 2019 – 2023e
Figure 8-21: Autobio Diagnostics - Global Revenue (Million US$), 2018 – 2023e
Figure 8-22: YHLO Biotech - Global Revenue (Million US$), 2019 – 2023e
Figure 8-23: Beijing Strong Biotechnologies, Inc. – China IVD Revenue (Million US$), 2018 – 2023e
Figure 8-24: Others - China IVD Revenue (Million US$), 2015 - 2023
Figure 8-25: Others - Forecast for China IVD Revenue (Million US$), 2024 - 2030

List of Tables

List of Tables:

Table 2-1: China - IVD Market Share (Percent), 2014 - 2023
Table 2-2: China - Forecast for IVD Market Share (Percent), 2024 - 2030
Table 2-3: China IVD Market - Company Share (Percent), 2015 - 2023
Table 2-4: China IVD Market - Forecast for Company Share (Percent), 2024 - 2030

Table 12-1: China Food and Drug Administration - Regulation and Impact for Medical Device and IVD Manufacturers Selling in China